Emerging gene editing platforms are revolutionizing precision medicine, enabling safe and effective genetic modifications for ...

The company seems to be doing everything it's supposed to be doing; the stock just isn't responding.

One company dominates with an approved therapy, while the other bets on in vivo innovation. See how their financials and risk ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the most shorted mid-cap and small-cap stocks to buy now. On May 27, research ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct gene-editing experiments. The device, CRISPR-GPT, is an artificial intelligence lab ...

The ‘base editing’ technique that researchers used is far from ready for the clinic, but critics worry it will spur a rush to ...

A team of researchers led by Luigi Naldini at the San Raffael Institute for Gene Therapy (SR-Tiget) has developed a new ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing "copilot" ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

Key Points Interested in Caribou Biosciences, Inc.? Here are five stocks we like better. Vispa-cel, Caribou's off-the-shelf ...

It sounds like something straight out of a futuristic movie, but scientists may have just moved one step closer to making it ...